Global Herpes Market 2014-2018

Category : Pharmaceuticals  | Published Date : Dec-2014 | Pages : 67
About Herpes
Generally, herpes covers two different diseases: oral herpes, also known as cold sores and genital herpes. While oral herpes affects the area around the mouth, genital herpes affects area around the genitals. The HSV-1 causes oral herpes; both HSV-1 and HSV-2 cause genital herpes. HSV is a contagious virus that spread through contact. At present, there is no cure for herpes, however, treatments can help reduce the pain and decrease healing period.
TechNavio's analysts forecast the Global Herpes market to grow at a CAGR of 10.14 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Herpes market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and vaccines used in the treatment and prevention of herpes simplex, herpes zoster and CMV infections that are available in the market.
The report also presents the vendor landscape and a corresponding detailed analysis of the vendors in the Global Herpes market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market.
Key Regions
• Americas 
• EMEA        
Key Vendors
• Gilead Sciences 
• GSK 
• Merck 
• Novartis 
Other Prominent Vendors
• Agenus 
• AiCuris 
• aRigen Pharmaceuticals
• Astellas Pharma
• CytoGenix
• Epiphany Biosciences
• F. Hoffmann-La Roche
• Genocea Biosciences
• NanoBio

Market Driver
• Significant Unmet Needs
• For a full, detailed list, view our report
Market Challenge
• Increasing Generic Competition
• For a full, detailed list, view our report
Market Trend
• Promising New Launches
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Product Profiles
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
07. Competitive Assessment of Marketed Products
07.1 Five Forces Analysis
08. Rate of Incidence and Prevalence
08.1.1 US
08.1.2 UK
09. Diagnosis of Herpes
10. Market Segmentation by Product Type
11. Market Segmentation by Type of Virus
12. Market Assessment of Top Drugs
12.1 Zovirax
12.1.1 Sales
12.2 Valtrex
12.2.1 Sales
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2013
21.3 Other Prominent Vendors
22. Key Vendor Analysis
22.1 Gilead Sciences
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Geographical Segmentation by Revenue 2013
22.1.4 Recent Developments
22.1.5 SWOT Analysis
22.2 GlaxoSmithKline
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue 2012 and 2013
22.2.5 Sales by Geography
22.2.6 Pipeline Products
22.2.7 Business Strategy
22.2.8 Key Information
22.2.9 SWOT Analysis
22.3 Merck & Co. Inc.
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation by Revenue 2013
22.3.4 Business Segmentation by Revenue 2012 and 2013
22.3.5 Sales by Geography
22.3.6 Business Strategy
22.3.7 Key Developments
22.3.8 SWOT Analysis
22.4 Novartis
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis
23. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Herpes Market 2013-2018 (US$ billion)
Exhibit 3: Diagnosis of Herpes
Exhibit 4: Global Herpes Market Segmentation by Type
Exhibit 5: GSK's Zovirax Revenue 2010-2013 (US$ million)
Exhibit 6: GSK's Valtrex Revenue 2010-2013 (US$ million)
Exhibit 7: Global Herpes Market by Geographical Segmentation 2013
Exhibit 8: Gilead Sciences: Geographical Segmentation by Revenue 2013
Exhibit 9: GlaxoSmithKline: Business Segmentation 2013
Exhibit 10: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 11: GlaxoSmithKline: Sales by Geography 2013
Exhibit 12: GlaxoSmithKline: Pipeline Products 2013
Exhibit 13: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 14: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 15: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 16: Novartis: Business Segmentation by Revenue 2013
Exhibit 17: Novartis: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 18: Novartis: Sales by Geography 2013
Publisher Name : Technavio

Published Reports
About Spinal Fusion Spinal fusion surgery is performed in many forms, and all are designed to help limit the pain caused by joints through surgery depending on conditions such as degenerative disc disease (DDD), spondylosyndesis or spondylodesis, and other small problems caused in spine vertebrae. Spine ....
US $2500
About Cystic Fibrosis Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited, chronic disease and is progressive in nature. The onset of cystic fibrosis typically occurs in early childhood or, rarely, at birth. The primary symptoms of cystic fibrosis include breathing difficulties, ....
US $2500
Summary Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of ....
US $1495

Upcoming Reports
Clinical nutrition products are type of pharmaceutical products, which help to keep patient healthy. They aid to improve metabolic system of the body by providing adequate supplements such as minerals, vitamins and others .
US $ 4148
Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) indicates APIs market gaining traction .
US $ 4148
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020
US $2850
Please Select Format
Single User: US $ 2500
Five User: US $ 2800
Site User: US $ 3500
Global User: US $ 10000

market research offer
Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.